Area of research
Dermatology · Pathology and Forensic Medicine
Research interest
Research interests include Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, and Autoimmune Bullous Skin Diseases.
Clinical characteristics of mycosis fungoides with angiotropism.
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.
European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.
Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France.
Atypical Gamma‐Delta‐Positive T‐Cell Lymphoproliferation With Clinical Features of Lymphomatoid Papulosis in Three Children
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Actinic keratosis: Current challenges and unanswered questions.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
Improving disease‐specific survival for patients with Sezary syndrome in the modern era of systemic therapies
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas.
Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides.
Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real-world French study.
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies.
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey
Exploring the Nonlymphocytic Cutaneous Microenvironment in Advanced Cutaneous T-Cell Lymphomas using Single-Cell RNA Sequencing.
CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas.
Epidemiological and serological characteristics of patients with late syphilis: A retrospective cohort of 76 patients.
Serum infliximab levels and clinical response in hidradenitis suppurativa
Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome.
Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patients
Primary cutaneous follicle centre lymphoma with secondary systemic evolution
Jadassohn-Dössekker's atypical tuberous myxedema: Report of three cases and review of literature.